fda indications for semaglutide New Weight Loss Medication Wegovy™ Approved by the FDA approves first-ever oral GLP-1RA

Currently, there are many studies focusing on more effective treatment of obesity and co-morbidities

Severe gastrointestinal adverse reactions have also been reported postmarketing with GLP-1 receptor agonists

Now here is the nuance that most articles miss

While the appeal of drops may be appealing to consumers who are squeamish about injectables, oral sublingual drops have another perk: their ability to bypass the digestive system, offering more efficient and faster delivery of the medication compared to traditional oral forms, such as digestible tablets, according to AgelessRx

Learn more about either pen or pill by selecting the tab below